University of Michigan
James S. (Jim) Koopman has been oriented to advancing public health since he entered the University of Michigan medical school in 1963. After completing a pediatrics residency at Harbor General Hospital in 1972 he spent two years as an EIS officer and then acting state epidemiologist in the state of Washington. Upon completing his EIS stint he worked for WHO in smallpox eradication in India. He saw the last cases of smallpox ever in Azamgarh district of Uttar Pradesh and also saw the devastating effects of the vaccine that was given to contacts of cases in a population that was mostly unimmunized. After becoming a tenured professor of epidemiology at the University of Michigan, Jim took a couple years off to start a CDC sponsored program in Mexico which mirrors the Epidemic Intelligence Service in the US. Upon completing this work, he changed his career from field epidemiology to promoting a science of infection transmission system analysis. His work, together with that of many other researchers, has demonstrated that the backbone of transmission systems for human adapted infectious agents is the pattern of contacts that direct the flow of infection through a population. But the key to control of many infections is vaccines. In that regard he has recently written two papers that present completely new ways to conceptualize how vaccines affect ongoing adaptation of viruses to escape immunity and to increase transmission. These SARS-CoV-2 papers create a basis to update vaccines by choosing among all of the observed mutations in a virus rather than choosing a particular strain of a virus as is done for influenza.
President & Chief Scientific Officer
Ilya B. Tsyrlov is a Russian-American biochemist, molecular toxicologist and virologist. He is known for his studies and research on enzymology, drug metabolism, environmental toxicology, bioinformatics, virology, and cancer. Tsyrlov has authored 4 monographs, and co-authored over 280 publications on microsomal, purified and recombinant monooxygenases, and mechanisms of CYP induction by xenobiotics.
Tsyrlov graduated in 1970 from Novosibirsk State Medical Academy, USSR, and received a PhD degree in Biochemistry from the same institution (1973). In 1983 Tsyrlov earned higher Doctor of Sciences degree (Biochemistry) from the Institute of Experimental Medicine, Russian Academy of Sciences. He held various positions at Institute of Molecular Biology and Biophysics in Russian Academy of Sciences including Head of Laboratory and Chair of the Department of Xenobiochemistry. In 1990, the US National Institutes of Health (NIH) hired him for a position of a Senior Enzymologist at the Laboratory of Molecular Carcinogenesis (headed by Harry Gelboin), National Cancer Institute. Since 1994 he held positions of Research Associate Professor/Professor/Visiting professor at the Department of Medicine, Mount Sinai School of Medicine (Icahn School of Medicine at Mount Sinai), New York, NY.
In 2005, Tsyrlov founded Xenotox, Inc, a life sciences consulting company implementing an earlier discovered site-directed synthesis of long-acting drugs, and studying the transactivation of the human herpesviruses by body burden dioxins. He was elected an Emeritus member of International Society for Study of Xenobiotics (ISSX).
Senior Vice President
Vaccine Research and Development
BlueWillow Biologics, USA
Ali I. Fattom, Chief Scientific Officer joined BlueWillow Biologics in November 2010 with 25 years of experience in vaccine research and development. He initiated his career as a vaccinologist at the National Institutes of Health, where he helped develop several vaccines including Pneumococcus conjugate vaccine and headed the effort for developing a S. aureus vaccine. He later joined Univax Biologics to pursue the development of conjugate vaccines against bacterial infections including Staphylococci. Following the merger between Univax and North American Biologics to form Nabi Biopharmaceuticals, Dr. Fattom assumed responsibility for other research activities and served as Vice President of Research from 2003 to 2010. He earned a B.S. from The Hebrew University of Jerusalem, a M.S. in microbiology from Tel-Aviv University, and a Ph.D. in Microbial Ecology from the Hebrew University of Jerusalem. From 1983–1986 he held an assistant professorship at Bir-Zeit University, Palestine. Dr. Fattom is author of over 70 peer-reviewed publications, and holds more than 20 patents.
Chair and Professor
University of Almerí
Luisa Maria Arvide Cambra is a Professor and Chair at the University of Almería (Spain). She is the Director of Research Group HUM113-Estudios Filológicos from Program of Research of Andalusian Government, where she has managed and directed several academic and scientific contracts and research projects, as well as a Member of European Scientific Institute (ESI) Team, Athens Institute for Education & Research (ATINER) in Greece, The Academic Genesis Platform (UAGP) in UK &Turkey and Experts of Academic Excellence Research Centre (EAERC) in Jordan; GI Social Sciences Forum (GISSF), in Malaysia; Akademica Nusa International Association of Social Sciences and Humanities, in UAE; Science Research Association (SCIREA); Academic Fora; Foundation for Social Sciences and Education Research (FSSER); etc.
She has published 14 books and over 100 articles and papers published in prestigious international journals and proceedings.
Honors and awards
-Included and enlisted in Marquis Who´s Who in the World, USA.
-Included and enlisted in 2000 Outstanding Intellectuals of the 21st Century 2011. International Biographical Centre. Cambridge, UK.
-Included and enlisted in Great Minds of 21st Century, American Biographical Institute. Raleigh, North Carolina, USA.
-Top 100 Professionals 2011. International Biographical Centre. Cambridge, UK
-Woman of the Year 2011 by the American Biographical Institute. Raleigh, North Carolina, USA.
-Deputy Director-General for Europe of International Biographical Centre. Cambridge, UK.
-Collaborator in QS World Intelligence Unit. London, UK.
-International Jury Member of Ana María Agüero Melnyczuk Awards. Buenos Aires, Argentina. June 2013.
Michigan State University
Reza Nassiri is a former Associate Dean of Global Health at the Michigan State University (MSU). He also served as MSU director of Institute of International Health. He is currently Professor of Pharmacology and Toxicology, Professor of Family and Community Medicine, and, lecturer in Global Health, Infectious Diseases and Tropical Medicine. He currently works on international public health issues relating to chronic diseases and has expertise in global health. He has made contributions in various fields of medical sciences including clinical investigation and health education. On the basis of his extensive experience and expertise in chronic infectious diseases including HIV/AIDS, TB as well as antimicrobial resistance and human gut microbiome, he developed clinical research programs in Brazil, South Africa, Haiti, Dominican Republic and Mexico. He had served as editorial board member for the journal of HIV and AIDS Review. He is currently on editorial board member for AIDS Patient Care and STDs. Prof. Nassiri has delivered seminar presentations on Tropical Medicine, HIV/AIDS, TB, Global Health and public health interventions in numerous national and international conferences and workshops. He is internationally recognized for his work in the areas of building effective international partnerships particularly in global health, community health, clinical care capacity building, and technical assistance mechanism. He is the founder of Michigan State University Osteopathic and Primary Health Clinic in Merida, Yucatan, Mexico. He has developed academic and research partnership programs with Federal University of Para Institute of Tropical Medicine in Belem, Brazil.
Ubon Ratchathani University
Pongsak Rattanachaikunsopon is a Professor in the Department of Biological Science at Ubon Ratchathani University, Thailand. He obtained a Bachelor of Science in Radiological Technology at Mahidol University, Thailand, and a Master of Science in Anatomy at Mahidol University, Thailand. He earned a Ph.D. in Molecular Biology at Lehigh University, Pennsylvania USA. His research of interest is biocontrol. His present research focuses on using bacteriophages (bacterial viruses) as alternatives to control animal and human diseases caused by pathogenic bacteria. He has published more than 50 papers in reputed journals and has been serving as an Editorial Board Member of more than 10 reputed Journals.
© i-Vaccines 2021. All rights reserved.